NasdaqGS:ALKSBiotechs
Will Debt-Funded Avadel Deal and 2026 CEO Shift Change Alkermes' (ALKS) Narrative?
Alkermes has reported Q4 2025 results showing revenue of US$384.55 million and net income of US$49.34 million, both lower than the prior year, alongside a new US$1.53 billion term-loan package and 2026 guidance that includes higher revenues and adjusted EBITDA but a GAAP net loss due to acquisition effects.
At the same time, long-serving CEO Richard Pops plans to retire in July 2026 with COO Blair Jackson set to take over, concentrating leadership around Alkermes’ shift toward proprietary...